{"schema_version":"secwatch.filing_event.v1","accession":"0001520138-23-000122","form_type":"8-K","ticker":"AXIL","cik":"0001718500","company_name":"Axil Brands, Inc.","filed_at":"2023-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.294615+00:00","generated_at":"2026-06-18T13:16:57.976926+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Reviv3 Procare raises $448k via private placement of 1.95M shares at $0.23/share","bullets":["Issued 1,947,175 shares of common stock at $0.23 per share to accredited investors.","Gross proceeds of $447,850.25; offering exempt under Rule 506(b) of Regulation D.","Outstanding shares after placement: 117,076,949 as of February 28, 2023.","Proceeds will be used for general corporate purposes; no minimum raise required."],"urls":{"canonical":"https://secwatch.observer/filing/0001520138-23-000122","json":"https://secwatch.observer/filing/0001520138-23-000122.json","markdown":"https://secwatch.observer/filing/0001520138-23-000122.md","text":"https://secwatch.observer/filing/0001520138-23-000122.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1718500/000152013823000122/0001520138-23-000122-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1718500/000152013823000122/rviv-20230302_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T13:16:57.976926+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f1c1c48145c6d78c95e5dc03b27b0ca8f9b34908","claim":"Axil Brands, Inc. entered into Securities Purchase Agreements with accredited investors valued at $447,850.25 (effective 2023-02-23).","evidence_excerpt":"On February 23, 2023, Reviv3 Procare Company (the “Company”), a Delaware corporation, issued in private placements to accredited investors an aggregate of 1,947,175 shares of its common stock, par value $0.0001 per share. The securities were issued at a purchase price of $0.23 per share for aggregate gross proceeds to the Company of $447,850.25.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1718500/000152013823000122/0001520138-23-000122-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"accredited investors"},{"label":"Value","value":"$447,850.25"},{"label":"Effective","value":"2023-02-23"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}